Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 2 Sarcoma 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Hemangioma, Capillary 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ulcer 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Skin Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Lymphatic Metastasis 1 Liver Neoplasms 1 Fallopian Tube Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

pembrolizumab 243 Carboplatin 211 Pemetrexed 177 Cisplatin 131 Paclitaxel 113 Nivolumab 101 Docetaxel 87 osimertinib 85 durvalumab 78 Specimen Handling 56 atezolizumab 55 Gemcitabine 52 Drug Therapy 52 Magnetic Resonance Spectroscopy 50 Radiosurgery 48 Radiotherapy 47 Ipilimumab 41 130-nm albumin-bound paclitaxel 39 cemiplimab 38 Bevacizumab 34 Cetuximab 30 tislelizumab 29 amivantamab 22 Taxes 22 Platinum Compounds 20 Blood Specimen Collection 20 Immunotherapy 18 Immune Checkpoint Inhibitors 18 Radiation 17 Erlotinib Hydrochloride 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Propranolol × 1 year × Clear all

NCT06120140 2026-06-05

COCOON

Janssen Research & Development, LLC

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡